The NCI-led Vanguard study has selected tests from Guardant Health and ClearNote Health to move forward after a vigorous technology assessment.
Combined with a new software update, the NovaSeq X 25B 100-cycle kits can generate several billion more reads per run than previously.
The Solvd Health AvertD assay for opioid use disorder risk could lead to false negative and false positive results, according to a study led by University of Pennsylvania researchers.
Geneoscopy Closes $105M Series C Financing Led by Bio-Rad to Market CRC Screening Test
Geneoscopy will also work with Labcorp to more broadly disseminate its stool-based test, which uses Bio-Rad's Droplet Digital PCR technology.
VarChat promises to not only retrieve relevant literature on a variant but also distill the information into digestible summaries.